122 related articles for article (PubMed ID: 38143011)
1. DHX33 mediates p53 to regulate mevalonate pathway gene transcription in human cancers.
Nie G; Chen S; Song Q; Zou D; Li M; Tang X; Deng Y; Huang B; Yang M; Lv G; Zhang Y
Biochim Biophys Acta Gen Subj; 2024 Mar; 1868(3):130547. PubMed ID: 38143011
[TBL] [Abstract][Full Text] [Related]
2. Targeting RNA helicase DHX33 blocks Ras-driven lung tumorigenesis in vivo.
Wang X; Feng W; Peng C; Chen S; Ji H; Zhong H; Ge W; Zhang Y
Cancer Sci; 2020 Oct; 111(10):3564-3575. PubMed ID: 32767810
[TBL] [Abstract][Full Text] [Related]
3. P19ARF and RasV¹² offer opposing regulation of DHX33 translation to dictate tumor cell fate.
Zhang Y; Saporita AJ; Weber JD
Mol Cell Biol; 2013 Apr; 33(8):1594-607. PubMed ID: 23401854
[TBL] [Abstract][Full Text] [Related]
4. RNA helicase DHX33 regulates HMGB family genes in human cancer cells.
Wang X; Chen S; Wen F; Zeng Y; Zhang Y
Cell Signal; 2023 Oct; 110():110832. PubMed ID: 37543097
[TBL] [Abstract][Full Text] [Related]
5. Identification of DHX33 as a mediator of rRNA synthesis and cell growth.
Zhang Y; Forys JT; Miceli AP; Gwinn AS; Weber JD
Mol Cell Biol; 2011 Dec; 31(23):4676-91. PubMed ID: 21930779
[TBL] [Abstract][Full Text] [Related]
6. Role of DHX33 in c-Myc-induced cancers.
Fu J; Liu Y; Wang X; Yuan B; Zhang Y
Carcinogenesis; 2017 Jun; 38(6):649-660. PubMed ID: 28498893
[TBL] [Abstract][Full Text] [Related]
7. DHX33 Interacts with AP-2β To Regulate
Wang J; Feng W; Yuan Z; Weber JD; Zhang Y
Mol Cell Biol; 2019 Sep; 39(17):. PubMed ID: 31182639
[TBL] [Abstract][Full Text] [Related]
8. DHX33 Transcriptionally Controls Genes Involved in the Cell Cycle.
Yuan B; Wang X; Fan C; You J; Liu Y; Weber JD; Zhong H; Zhang Y
Mol Cell Biol; 2016 Dec; 36(23):2903-2917. PubMed ID: 27601587
[TBL] [Abstract][Full Text] [Related]
9. Recombinant DHX33 Protein Possesses Dual DNA/RNA Helicase Activity.
Wang X; Ge W; Zhang Y
Biochemistry; 2019 Jan; 58(4):250-258. PubMed ID: 29870660
[TBL] [Abstract][Full Text] [Related]
10. DHX33 promotes colon cancer development downstream of Wnt signaling.
Zhu Y; Du Y; Zhang Y
Gene; 2020 Apr; 735():144402. PubMed ID: 32004669
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
12. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
[TBL] [Abstract][Full Text] [Related]
13. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo.
Pereira M; Glogova A; Haagsma J; Stewart J; Shepherd TG; Petrik J
J Ovarian Res; 2023 Nov; 16(1):218. PubMed ID: 37986175
[TBL] [Abstract][Full Text] [Related]
14. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
[TBL] [Abstract][Full Text] [Related]
15. Targeting mutant p53 through the mevalonate pathway.
Freed-Pastor W; Prives C
Nat Cell Biol; 2016 Oct; 18(11):1122-1124. PubMed ID: 27784901
[TBL] [Abstract][Full Text] [Related]
16. Function of DHX33 in promoting Warburg effect via regulation of glycolytic genes.
Peng C; Hou ST; Deng CX; Zhang Y
J Cell Physiol; 2021 Feb; 236(2):981-996. PubMed ID: 32617965
[TBL] [Abstract][Full Text] [Related]
17. The RNA helicase DHX33 is required for cancer cell proliferation in human glioblastoma and confers resistance to PI3K/mTOR inhibition.
Wang H; Yu J; Wang X; Zhang Y
Cell Signal; 2019 Feb; 54():170-178. PubMed ID: 30552990
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of immune implication and prognostic value of DHX33 in sarcoma.
Zhang X; Shao Y; Zhou Y; Zhu Z; Wang X
Medicine (Baltimore); 2023 Apr; 102(17):e33654. PubMed ID: 37115050
[TBL] [Abstract][Full Text] [Related]
19. The interplay between mutant p53 and the mevalonate pathway.
Parrales A; Thoenen E; Iwakuma T
Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
[TBL] [Abstract][Full Text] [Related]
20. Systematic analysis of the prognostic and immunological role of DHX33 in pan-cancer.
Ding J; Zhou J; Shen X; Zhang M; Feng X; Xu Z
Environ Toxicol; 2023 Aug; 38(8):2011-2021. PubMed ID: 37256545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
